IP Library Granted Patent US 8,506,951
Granted Patent B2
US 8,506,951 · App. 13/212,409 · Granted Aug 13, 2013

Methods of treating pigs with

Inventors: Thomas G. Rehberger (Wauwatosa, WI); Mari Ellen Davis (Waukesha, WI); Ashley Baker (Waukesha, WI)
Assignee: DuPont Nutrition Biosciences ApS
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,506,951
App. No.
13/212,409
Granted
Aug 13, 2013
Kind
B2
Abstract

Disclosed are methods of administering at least two Bacillus strains to a pig, such as female breeding stock, nursery pigs, or other pigs. The Bacillus strains inhibit Clostridium in litters borne to the pig. The Bacillus strains also are useful when administered to herds lacking symptoms of Clostridium infection. Administration of the Bacillus strains improves performance of female breeding stock and in piglets borne by the female breeding stock.

Claims (17)

1. A method comprising administering to one or more pig an effective amount to inhibit Clostridium in the one or more pig of at least two Bacillus strains selected from strains 22CP1 (ATCC PTA-6508), 3AP4 (ATCC PTA-6506), 15AP4 (ATCC PTA-6507), 2084 (NRRL B-50013), LSSAO1 (NRRL B-50104), and 27 (NRRL B-50105), wherein at least one strain is LSSAO1 (NRRL B-50104).

2. The method of claim 1 , wherein the Bacillus strains are strains 3AP4 (ATCC PTA-6506) and LSSAO1 (NRRL B-50104).

3. The method of claim 1 , wherein the Bacillus strains are administered in substantially equal amounts of CFUs.

4. The method of claim 3 , wherein the Bacillus strain is administered to one or more nursery pig.

5. The method of claim 4 , wherein a total microbial count of 3.75×10 5 CFU/g of feed is administered.

6. The method of claim 4 , wherein administration of the Bacillus strains provides at least one of the following in the one or more nursery pig relative to that in pigs that have not been administered the Bacillus strains: (A) an improvement in average daily gain, (B) an increase in body weight, and (C) an increase in average daily feed intake.

7. The method of claim 4 , wherein performance of the one or more nursery pig is improved relative to nursery pigs that have not been administered the Bacillus strains.

8. The method of claim 1 , wherein the Clostridium is Clostridium perfringens.

9. The method of claim 1 , wherein the Clostridium is Clostridium difficile.

10. The method of claim 1 , further comprising modifying the Bacillus strains administered based on a change in Clostridium strains to which the one or more pig is exposed.

11. The method of claim 1 , wherein the Bacillus strains are strains 15AP4 (ATCC PTA-6507) and LSSA01 (NRRL B-50104).

12. The method of claim 1 , wherein the one or more pig is in a herd lacking symptoms of Clostridium infection.

13. The method of claim 1 , wherein the one or more pig is in a unit of pigs that are subclinical for clostridial scours.

14. The method of claim 1 , wherein the Bacillus strain is administered to one or more grow-finish pig.

15. A method comprising administering to one or more nursery pig an effective amount to inhibit Clostridium in the one or more nursery pig of at least two Bacillus strains selected from a strain having all of the characteristics of 22CP1 (ATCC PTA-6508), a strain having all of the characteristics of 3AP4 (ATCC PTA-6506), a strain having all of the characteristics of 15AP4 (ATCC PTA-6507), a strain having all of the characteristics of 2084 (NRRL B-50013), a strain having all of the characteristics of LSSAO1 (NRRL B-50104), and a strain having all of the characteristics of 27 (NRRL B-50105), wherein at least one Bacillus strain has all of the identifying characteristics of LSSAO1 (NRRL B-50104).

16. The method of claim 15 , wherein at least one Bacillus strain has all of the identifying characteristics of 3AP4 (ATCC PTA-6506).

17. The method of claim 15 , wherein at least one Bacillus strain has all of the identifying characteristics of 15AP4 (ATCC PTA-6507).

Continuity (3)
Continuation 12404149 · Mar 13, 2009
Provisional Application 61036741 · Mar 14, 2008
Related Publication 20120100118A1 · Apr 26, 2012